Chemo Genics Bio Pharma
Pharmaceuticals, 104 W Alexander Dr, Research Triangle Park, North Carolina, 27709, United States, 1-10 Employees
Phone Number: +19*********
Who is CHEMOGENICS BIOPHARMA
Contribution to design and synthesis of Phase 2 Clinical Compounds: Trilaciclib and Lerociclib ChemoGenics BioPharma excels in multiple phases of preclinical drug discovery. Our core stre...
Read More
-
Headquarters: 104 W Alexander Dr, Research Triangle Park, North Carolina, 27709, United States
-
Date Founded: 2008
-
Employees: 1-10
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from CHEMOGENICS BIOPHARMA
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding ChemoGenics BioPharma
Answer: ChemoGenics BioPharma's headquarters are located at 104 W Alexander Dr, Research Triangle Park, North Carolina, 27709, United States
Answer: ChemoGenics BioPharma's phone number is +19*********
Answer: ChemoGenics BioPharma's official website is https://chemogenicsbiopharma.com
Answer: ChemoGenics BioPharma's revenue is $1 Million to $5 Million
Answer: ChemoGenics BioPharma's SIC: 2834
Answer: ChemoGenics BioPharma's NAICS: 325412
Answer: ChemoGenics BioPharma has 1-10 employees
Answer: ChemoGenics BioPharma is in Pharmaceuticals
Answer: ChemoGenics BioPharma contact info: Phone number: +19********* Website: https://chemogenicsbiopharma.com
Answer: Contribution to design and synthesis of Phase 2 Clinical Compounds: Trilaciclib and Lerociclib ChemoGenics BioPharma excels in multiple phases of preclinical drug discovery. Our core strengths are Medicinal Chemistry, process optimization, scale up, animal (rodent) dosing studies, DMPK, bioanalytical studies (tissue and plasma matrices). We have several collaborative medicinal chemistry programs in various target areas. Our internally developed compound has entered human trials as a first in class chemoprotective agent. We have several other compounds entering human clinical trials for other indications. We want to use our expertise to help companies identify molecules that could enter human clinical trials. State of art instrumentation for bioanalytical work: Sciex 4000QTRAP, Sciex 5500 coupled to Agilent HPLC/UPLC
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month